Inhibition of DNA-dependent protein kinase catalytic subunit by small molecule inhibitor NU7026 sensitizes human leukemic K562 cells to benzene metabolite-induced apoptosis

Abstract

Benzene is an established leukotoxin and leukemogen in humans. We have previously reported that exposure of workers to benzene and to benzene metabolite hydroquinone in cultured cells induced DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to mediate the cellular response to DNA double strand break (DSB) caused by DNA-damaging metabolites. In this study, we used a new, small molecule, a selective inhibitor of DNA-PKcs, 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026), as a probe to analyze the molecular events and pathways in hydroquinone-induced DNA DSB repair and apoptosis. Inhibition of DNA-PKcs by NU7026 markedly potentiated the apoptotic and growth inhibitory effects of hydroquinone in proerythroid leukemic K562 cells in a dose-dependent manner. Treatment with NU7026 did not alter the production of reactive oxygen species and oxidative stress by hydroquinone but repressed the protein level of DNA-PKcs and blocked the induction of the kinase mRNA and protein expression by hydroquinone. Moreover, hydroquinone increased the phosphorylation of Akt to activate Akt, whereas co-treatment with NU7026 prevented the activation of Akt by hydroquinone. Lastly, hydroquinone and NU7026 exhibited synergistic effects on promoting apoptosis by increasing the protein levels of pro-apoptotic proteins Bax and caspase-3 but decreasing the protein expression of anti-apoptotic protein Bcl-2. Taken together, the findings reveal a central role of DNA-PKcs in hydroquinone-induced hematotoxicity in which it coordinates DNA DSB repair, cell cycle progression, and apoptosis to regulate the response to hydroquinone-induced DNA damage.

Keywords

benzene / DNA-dependent protein kinase catalytic subunit / 2-(morpholin-4-yl)-benzo[h]chomen-4-one / Akt / DNA double strand break

References

[1] ATSDR.. . Toxicological Profile for Benzene, 1997, Atlanta, GA, Public Health Service

[2] SnyderR., WitzG., GoldsteinB.D.. The toxicology of benzene. Environ Health Perspect, 1993, 100(8): 293-306

[3] AksoyM.. Hematotoxicity and carcinogenicity of benzene. Environ Health Perspect, 1989, 82(7): 193-197

[4] GoldsteinB.D.. Benzene as a cause of lymphoproliferative disorders. Chem Biol Interact, 2010, 184(1–2): 147-150

[5] BirdM.G., GreimH., KadenD.A., et al.. Benzene 2009—Health effects and mechanisms of bone marrow toxicity: implications for t-AML and the mode of action framework. Chem Biol Interact, 2010, 184(1–2): 3-6

[6] GasiewiczT.A., SinghK.P., CasadoF.L.. The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity. Chem Biol Interact, 2010, 184(1–2): 246-251

[7] ForrestM.S., LanQ., HubbardA.E., et al.. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect, 2005, 113(6): 801-807

[8] ZhaoZ., HeX., BiY., et al.. Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils. Drug Metab Dispos, 2009, 37(2): 282-291

[9] BiY., LiY., KongM., et al.. Gene expression in benzene-exposed workers by microarray analysis of peripheral mononuclear blood cells: induction and silencing of CYP4F3A and regulation of DNA-dependent protein kinase catalytic subunit in DNA double strand break repair. Chem Biol Interact, 2010, 184(1–2): 207-211

[10] LanQ., ZhangL., LiG., et al.. Hematotoxicity in workers exposed to low levels of benzene. Science, 2004, 306(5702): 1774-1776

[11] HirabayashiY., InoueT.. Benzene-induced bone-marrow toxicity: a hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect. Chem Biol Interact, 2010, 184(1–2): 252-258

[12] SnyderR., HedliC.C.. An overview of benzene metabolism. Environ Health Perspect, 1996, 104(Suppl6): 1165-1171

[13] MaQ.. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther, 2010, 125(3): 376-393

[14] SubrahmanyamV.V., RossD., EastmondD.A., et al.. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic Biol Med, 1991, 11(5): 495-515

[15] O’DriscollM., JeggoP.A.. The role of double-strand break repair—insights from human genetics. Nat Rev Genet, 2006, 7(1): 45-54

[16] ChuG.. Double strand break repair. J Biol Chem, 1997, 272(39): 24 097-24 100

[17] KhannaK.K., JacksonS.P.. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet, 2001, 27(3): 247-254

[18] RouseJ., JacksonS.P.. Interfaces between the detection, signaling, and repair of DNA damage. Science, 2002, 297(5581): 547-551

[19] FalckJ., CoatesJ., JacksonS.P.. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature, 2005, 434(7033): 605-611

[20] KanaarR., HoeijmakersJ.H., van GentD.C.. Molecular mechanisms of DNA double strand break repair. Trends Cell Biol, 1998, 8(12): 483-489

[21] CollisS.J., DeWeeseT.L., JeggoP.A., et al.. The life and death of DNA-PK. Oncogene, 2005, 24(6): 949-961

[22] XiaoX., SongW., BiY.. Role of DNA-PKcs in the biological effect of a benzene metabolite: phenol toxicity to human K562 cells in vitro. Chem Biol Interact, 2010, 184(1–2): 302-305

[23] WillmoreE., de CauxS., SunterN.J., et al.. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood, 2004, 103(12): 4659-4665

[24] VeugerS.J., CurtinN.J., RichardsonC.J., et al.. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res, 2003, 63(18): 6008-6015

[25] BozulicL., SurucuB., HynxD., et al.. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell, 2008, 30(2): 203-213

[26] SantessonC.G.. Uber chronische vergiftungen mit steinkohlenteerbenzen: vier todesfalle. Arch Hyg Berl, 1897, 31: 336-376

[27] SellingL.. Benzol as a leucotoxin. Studies on the degeneration of the blood and haematopoietic organs. Johns Hopkins Hosp Rep, 1916, 17: 83-148

[28] FalconerE.H.. An instance of lymphatic leukemia following benzol poisoning. Am J Med Sci, 1933, 186: 353-361

[29] ViglianiE.C., SaitaG.. Benzene and leukemia. N Engl J Med, 1964, 271: 872-876

[30] BrazilD.P., YangZ.Z., HemmingsB.A.. Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci, 2004, 29(5): 233-242

[31] DragoiA.M., FuX., IvanovS., et al.. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J, 2005, 24(4): 779-789

[32] Lees-MillerS.P., GodboutR., ChanD.W., et al.. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science, 1995, 267(5201): 1183-1185

[33] XuW., LiuL., SmithC.G., et al.. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat Cell Biol, 2000, 2(6): 339-345